Related by context. All words. (Click for frequent words.) 76 Joel Sendek 73 analyst Jim Reddoch 72 analyst Mark Monane 71 Bret Holley 69 analyst Cory Kasimov 69 analyst Jim Birchenough 69 analyst Geoffrey Meacham 69 Dr. Jim Birchenough 69 analyst Mark Schoenebaum 68 Eric Ende 68 Jonathan Aschoff 68 analyst Amit Hazan 67 Akhtar Samad 67 David Amsellem 66 analyst Randall Stanicky 66 analyst Simos Simeonidis 66 Joshua Schimmer 66 Jim Reddoch 65 Mark Monane 65 analyst Yaron Werber 65 Jason Gurda 64 Mark Schoenebaum 64 Phil Nalbone 64 Jim Birchenough 64 Geoff Porges 64 reaffirmed Outperform rating 64 Jason Kantor 64 Cory Kasimov 64 analyst Lawrence Keusch 64 analyst Glenn Novarro 64 analyst Robert Cihra 64 Annabel Samimy 64 Geoff Meacham 63 Steven Harr 63 Geoffrey Meacham 63 Edward Tenthoff 63 analyst Jami Rubin 63 Chris Shibutani 63 Monane 62 Gbola Amusa 62 Bert Hazlett 62 Yaron Werber 62 analyst Ananda Baruah 62 Larry Biegelsen 62 Jon LeCroy 62 Sam Fazeli 62 analyst Ken Trbovich 62 analyst Liana Moussatos 62 analyst Maged Shenouda 62 analyst Raj Denhoy 62 Jami Rubin 61 Ananda Baruah 61 analyst Geoffrey Porges 61 Bruce Cranna 61 analyst Bruce Nudell 61 analyst Larry Biegelsen 61 Vertex hepatitis C 61 Dr. Joshua Schimmer 61 Geoffrey Porges 60 Holger Blum 60 Moussatos 60 analyst Seamus Fernandez 60 Joseph Pantginis 60 Elan Tysabri 60 Jason Kolbert 60 reaffirmed Market Perform 60 analyst Eric Beder 60 Liisa Bayko 60 Kenji Masuzoe 60 Tao Levy 60 analyst Sapna Srivastava 60 analyst Joanne Wuensch 60 Amylin Eli Lilly 59 Pantginis 59 Leerink Swan 59 analyst Hari Sambasivam 59 analyst Gurinder Kalra 59 Alexandra Hauber 59 analyst Alexandra Hauber 59 Kochnover 59 George Grofik 59 analyst Bruce Cranna 59 Glenn Novarro 59 Liana Moussatos 59 Ken Cacciatore 59 Andrew Vaino 59 Ian Somaiya 59 Andreas Theisen 59 David Molowa 59 Medivation Inc 59 analyst Glenn Reicin 58 Dr. Yaron Werber 58 Stanicky 58 Kevin Scotcher 58 analyst Andrey Glukhov 58 NASDAQ ACOR 58 Bruce Nudell 58 Small Cap Institutional Investor 58 reaffirmed Neutral 58 Celgene Revlimid 58 Affymax AFFY 58 Forest Labs FRX 58 MyVax 58 Jon Lecroy 58 Carl Seiden 58 Eun K. 58 Eric Coldwell 58 United Therapeutics UTHR 58 Gary Nachman 58 Lawrence Biegelsen 58 Roopesh Patel 58 James Kumpel 58 midstage clinical 57 Ziopharm 57 Seamus Fernandez 57 analyst Amit Bhalla 57 Nasdaq IDIX 57 Grofik 57 analyst Tim Savageaux 57 Vertex VRTX 57 Mark Bacurin 57 Bifeprunox 57 Reiterates Hold 57 Jeffrey Frelick 57 Piper Jaffray PJC 57 Cantor Fitzgerald reiterates 57 analyst Ajit Pai 57 Lauren Cooks Levitan 57 Brean Murray 57 Joanne Wuensch 57 Betsy Van Hees 57 Kin Ho 57 analyst Elemer Piros 57 analyst Gbola Amusa 57 Jeffrey Holford 57 Maintains Overweight 57 Ronny Gal 56 Quynh Pham 56 analyst Greg Mesniaeff 56 IG HCR ;) CO 56 analyst Randal Konik 56 Sepracor SEPR 56 Dhulsini de Zoysa 56 CE Unterberg 56 Joe Pantginis 56 Karl Heinz Scheunemann 56 Molowa 56 Curagen 56 Cubist Pharma 56 Tenthoff 56 Leerink Swann 56 Resumes Coverage 56 Leerink 56 Ulrich Huwald 56 analyst Tore Svanberg 56 BWS Financial 56 Adventrx 56 Jerry Doctrow 56 Isis Pharma 56 analyst Phillip Nalbone 56 analyst Lori Appelbaum 56 Kalpesh Kapadia 56 Sara Michelmore 56 analyst Shebly Seyrafi 56 analyst George Grofik 56 Lazard Capital 56 analyst Ross Muken 56 Maintains Neutral 56 NASDAQ ONXX 56 Amgen Prolia 56 analyst Rommel Dionisio 56 Dendreon Provenge 56 NASDAQ REGN 56 Muraglitazar 56 JoAnne Feeney 56 drug Treanda 56 Ahmar Zaman 56 analyst Tony Wible 56 analyst Dan Wantrobski 56 Navdeep Jaikaria 55 Satya Chillara 55 Seattle Genetics SGEN 55 Sparlon 55 Inc CYBX 55 Daniel Berenbaum 55 analyst Bijan Moazami 55 Pfizer inhaled insulin 55 ImmunoCellular Therapeutics 55 Ariad Pharmaceuticals 55 analyst Jeff Fidacaro 55 analyst Annabel Samimy 55 Atsushi Seki 55 Raj Denhoy 55 Amylin AMLN 55 Celgene NASDAQ CELG 55 Rajesh Ghai 55 Schoenebaum 55 Simos Simeonidis 55 Mike Krensavage 55 Reiterates Buy 55 Funtleyder 55 analyst Uche Orji 55 Biegelsen 55 analyst Frank Mitsch 55 analyst Christa Quarles 55 Novartis Gilenia 55 Hamed Khorsand 55 Randal Konik 55 Reiterates Outperform 55 AstraZeneca Iressa 55 Randall Stanicky 55 analyst Emme Kozloff 55 Inc. NASDAQ ITMN 55 Arena Pharmaceuticals ARNA 55 Oxigene 55 Trevor Polischuk 55 Xenoport 55 analyst Srini Pajjuri 55 Orexigen Contrave 55 Glenn Reicin 55 Carsten Kunold 55 RBC Capital Mkts Reiterate 55 Xenoport Inc. 55 TSRX 55 AMAG Pharma 55 Sven Borho partner 55 Maintains Buy 55 Natixis Bleichroeder analyst 55 analyst Robert Koort 55 David Turkaly 55 Birgit Kulhoff 55 Equal Weight rating 55 Maintains Hold 55 Matt Miksic 55 Rob Cihra 55 Lawrence Keusch 54 Cinquil 54 Assumes Coverage 54 Reiterates Buy Rating 54 midstage trials 54 Canvaxin 54 Dr. Gail Cawkwell 54 ABX EGF 54 Biogen Idec Elan 54 Merck KGaA Erbitux 54 Vorapaxar 54 Auxilium Pharma 54 analyst Peter Misek 54 Intermune 54 Avanir 54 analyst Jason Gurda 54 Reiterates Neutral Rating 54 Amgen denosumab 54 Geoff Ruddell 54 Joe Osha 54 Scott Geels 54 Preos 54 Reiterates Hold Rating 54 Biomarin 54 Kiacta 54 analyst Edwin Mok 54 Justin Hott 54 WR Hambrecht reiterate 54 NASDAQ VRTX 54 analyst Bruce Harting 54 analyst Jonathan Schildkraut 54 Tykerb lapatinib 54 Saftlas 54 Barclays Capital Reiterate Overweight 54 Dificid 54 Conviction Sell 54 ImClone Erbitux 54 Underweight rating 54 Dorothy Lakner 54 Inc. NASDAQ ACOR 54 generic Lovenox 54 Reiterate Buy rating 54 AUXL 54 Rachael Rothman 54 ThinkEquity downgraded 54 Aaron Reames 54 Amylin Pharmaceuticals Nasdaq AMLN 54 ONXX 54 OPTR 54 Krystexxa 54 Optimer Pharmaceuticals 54 Impax Laboratories IPXL 54 Co. LLY.N 54 analyst Thilo Wrede 53 Co LLY.N 53 Aegerion Pharmaceuticals Inc. 53 James Manuso 53 Nasdaq AVNR 53 Millennium Velcade 53 Submits Response 53 Celgene CELG 53 pulls Darvon painkiller 53 analyst Charles Boorady 53 Benlysta belimumab 53 Bayer BAY.ETR 53 AstraZeneca AZN.ISE 53 analyst Mehdi Hosseini 53 Michael Krensavage 53 analyst Robyn Karnauskas 53 Martin Possienke 53 Nasdaq SLXP 53 analyst Joshua Shanker 53 IDIX 53 ViroPharma VPHM 53 Rating Reiterated 53 Rating Maintained 53 analyst Lawrence Klatzkin 53 Olav Zilian 53 Teva Pharmaceutical TEVA 53 Bristol Myers BMY 53 Vijay Rakesh 53 Jesse Pichel 53 Nicholas Landekic 53 Inhibitex INHX 53 analyst Adrienne Tennant 53 Analyst Rebecca Arbogast 53 Scott Mushkin 53 Idenix Pharmaceuticals Inc. 53 Novo Nordisk NOVOb.CO 53 Barclays Maintains 53 Regeneron Pharma 53 Alimta pemetrexed 53 Dynavax Technologies 53 Recentin 53 authority Gurian Sherman 53 Financial XLF Bearish 53 Amgen Vectibix 53 IVGN 53 Jonathan Ruykhaver 53 generic Copaxone 53 Analysts Initiate Coverage 53 analyst Steven Wieczynski 53 Brean Murray Carret 53 Keay Nakae 53 Idenix Pharmaceuticals 53 Pulminiq 53 ThinkEquity LLC 53 John DiFucci 53 Piper Jaffray reiterates 53 Vertex Pharmaceuticals NASDAQ VRTX 53 analyst William Pecoriello 53 Damien Conover 53 Leerink Swann analyst 53 analyst Maarten Altena 53 Ironwood Pharmaceuticals Inc. 53 Celgene Corp. 53 analyst Alex Gauna 53 Nasdaq ONXX 53 Arcalyst 53 NASDAQ ARIA 53 Punk Ziegel 53 BioMarin Pharma 53 Simponi golimumab 53 Remi Barbier 53 Edwin Hemwall 53 Eric Beder 53 Technology XLK Bearish 53 Thom Gunderson 53 SEPR 53 analyst Tim Klasell 53 Christopher Danely 53 analyst Richard Fetyko 53 blood thinner prasugrel 53 Kemp Dolliver 53 analyst Joseph Altobello 53 Nuedexta 53 Lowers Estimates 52 Neutral Weight 52 Astellas Pharma #.T 52 analyst Junaid Husain 52 Optimer Pharma 52 analyst Ghansham Panjabi 52 Fusilev 52 analyst Colby Synesael 52 Onyx Pharma 52 MBRX 52 Matthew Borsch 52 Omapro 52 Consumer Discretionary XLY Bearish 52 DepoMed 52 NEUTRAL rating 52 Oncogenex 52 NASDAQ ENDP 52 analyst Laura Champine 52 CE Unterberg Towbin 52 Tesofensine 52 Timothy Arcuri 52 Nicholas Aberle 52 Eyetech Pharmaceuticals 52 Abbott Niaspan 52 Syncria 52 Nasdaq BMRN 52 Ajit Pai 52 Deane Dray 52 Schering SHR 52 Navid Malik 52 Alnylam Nasdaq ALNY 52 NASDAQ BMRN 52 Piper Jaffray Reiterates 52 analyst Charles Grom 52 Steven Brozak 52 Incyte INCY 52 analyst Margaret Mager 52 analyst Ashwin Shirvaikar 52 FBR Capital Maintains 52 David Hochstim 52 analyst Dinesh Moorjani 52 analyst Dara Mohsenian 52 MOGN 52 Michael Leuchten 52 analyst Richard Kugele 52 analyst Louis Miscioscia 52 Co. MRK.N 52 Prolor 52 compound INCB# 52 Michael Masdea 52 Overweight rating 52 Phillip Nalbone 52 Energy XLE Bearish 52 Isaac Ro 52 analyst Christopher Danely 52 Tony Clapsis 52 InterMune ITMN 52 Elan Biogen 52 Allos Therapeutics Incorporated 52 PiperJaffray 52 Inc. NASDAQ HGSI 52 NASDAQ QCOR 52 Wedbush Maintains 52 NGSX 52 Kash Rangan 52 Orbimed Advisors LLC 52 Roche Herceptin 52 Jeremy Sussman 52 Eli Lilly NYSE LLY 52 ZIOP 52 Roche Mircera 52 analyst Youssef Squali 52 Tocosol Paclitaxel 52 analyst Kristine Koerber 52 SGEN 52 Atherogenics 52 experimental lupus 52 Ken Trbovich 52 Analyst Cai von 52 Nasdaq IPXL 52 analyst Christopher Growe 52 strategist Makoto Yamashita 52 Tristan Gerra 52 analyst Mahesh Sanganeria 52 Analyst Cody Acree 52 Avanir Pharmaceuticals 52 Vioxx Zocor 52 analyst Alan Bezoza 52 Philip Alling 52 Hologic NASDAQ HOLX 52 analyst Jesse Pichel 52 Piper Jaffray Upgrades 52 AMLN 52 analyst Jason Brueschke 52 Broker Panmure Gordon 52 analyst Joseph Greff 52 Amylin Byetta 52 OGXI 52 INCY 52 Simeonidis 52 MAP Pharma 52 analyst Rebecca Runkle 52 John Calcagnini 52 Neuvenge 52 Riluzole 52 Peer Perform rating 52 QLT QLTI 52 NASDAQ ALXN 52 D mab 51 analyst Julio Quinteros 51 Cyclacel Pharmaceuticals 51 Sena Lund 51 Rigel Pharmaceuticals 51 analyst Tristan Gerra 51 analyst Shaul Eyal 51 Donald Fandetti 51 analyst Timothy Conder 51 NASDAQ GPRO 51 HIV treatments Reyataz 51 Piper Jaffray 51 Chris Brendler 51 PiperJaffray analyst 51 Corlux 51 Swiss brokerage Helvea 51 aerosolized AAT 51 PF # [002] 51 Theo Kitz 51 Spiegelmer ® 51 Encysive Pharmaceuticals 51 Sunesis Pharmaceuticals 51 Colazal 51 Wells Fargo Initiates Coverage 51 SG Cowen 51 Brion Tanous 51 Vertex telaprevir 51 Dr. Pazdur 51 ThinkEquity 51 Healthcare Conf 51 BernsteinResearch 51 Claude Camire 51 Achillion Pharmaceuticals 51 NASDAQ ADLR 51 analyst Randy Binner 51 Roche Actemra 51 Matthew Heimermann 51 SLXP 51 strategist Tony Crescenzi 51 BiolineRX 51 Kristine Koerber 51 Acorda Therapeutics ACOR 51 Questcor Pharmaceuticals QCOR 51 Vertex Pharmaceuticals VRTX 51 FBR Capital Reiterates 51 FBR Capital Upgrades 51 Steven Wieczynski 51 J.P. Morgan Healthcare 51 Piper Jaffrey 51 Risperidone Oral Solution 51 analyst Michael Exstein 51 Fablyn 51 Vion Pharmaceuticals 51 newratings.com Analyst Jonathan Aschoff 51 Gets Downgraded 51 Suntrust Robinson Humphrey 51 analyst Pablo Zuanic 51 Novo Nordisk Victoza 51 ALXA 51 Thoratec Presentation 51 Singulair asthma 51 analyst Martijn den 51 Peter Nesvold 51 Claudia Shank Hueston 51 Vishal Shreedhar 51 QCOR 51 analyst Stephen Tusa 51 baminercept 51 Inc. NASDAQ VVUS 51 SILENOR 51 Afrezza 51 Sven Borho 51 Inc. NASDAQ EVVV 51 analyst Deane Dray 51 Mabthera 51 Alexion Pharmaceuticals ALXN 51 novel therapeutic antibodies 51 Nasdaq GPRO announced 51 Analysts Downgrade 51 NASDAQ INFI 51 Dominic Valder 51 solanezumab 51 Nasdaq INCY 51 analyst Robert Drbul 51 analyst Jeffrey Zekauskas 51 ImmunoGen IMGN 51 Brean Murray downgrades 51 Vertex Pharmaceuticals Nasdaq VRTX 51 Camvia 51 Robert Koort 51 Asmanex 51 ThinkEquity upgraded 51 Genentech Rituxan 51 Intravitreal 51 Reiterates Strong 51 analyst Romit Shah 51 sitaxsentan 51 GILD GILD 51 Biogen Nasdaq BIIB 51 Sterling Auty 51 WR Hambrecht 51 Wedbush Morgan downgrades 51 Heplisav 51 Pfizer Camptosar 51 THRX 51 Neibor 51 Savvas Neophytou 51 Merck boceprevir 51 Drew Fromkin President 51 analyst Amit Daryanani 51 NV1FGF 51 PDL Biopharma 51 analyst Anthony Chukumba 51 IDEV 51 liprotamase 51 Romit Shah 51 William Tanona 51 Amylin Pharma 51 CADX 51 Inc. Nasdaq VRUS 51 Neely Tamminga 51 Al Kaschalk 51 Co. nyse LLY 51 Myriad Genetics Inc 51 Inc. Nasdaq IMGN 51 analyst Daniel Renouard 51 Finncap 51 Matt Nemer 51 analyst Mark Lipacis 51 ALXN 51 Karl Heinz Koch 51 Genentech Herceptin 51 Inc. NASDAQ ELGX 51 Tee Sze Chiah 50 Genzyme Nasdaq GENZ 50 THG EPO 50 NASDAQ SLXP 50 SSRX 50 analyst Donald Fandetti 50 Zarnestra 50 Safi Bahcall Ph.D. 50 Paul Cuddon 50 Therapeutic Competitors 50 Adrienne Tennant 50 WBB Securities LLC 50 Industrial XLI Bearish 50 Lazard Capital Markets 50 spokeswoman Christine Fanelle 50 Ardea Biosciences 50 analyst Kimberly Greenberger 50 Douglas Anmuth 50 Dr. LaMattina 50 spokeswoman Lenore Gelb 50 HCl capsules 50 David Begleiter 50 Maintains Outperform 50 Lazard Capital reiterate 50 analyst Jeffrey Fidacaro 50 SCRX 50 analyst Silke Stegemann 50 CETP inhibitor 50 Nasdaq RDEA 50 Edwards Lifesciences EW 50 analyst Justin Yagerman 50 Aceon 50 Nexavar sorafenib 50 Therapeutic Competitors Companies 50 BMRN 50 Luuk van Beek 50 Matt DiFrisco 50 Andy Kaplowitz 50 analyst Gregory Melich 50 Trius Therapeutics 50 Citi Initiates Coverage 50 Therapeutic Competitors companiesandmarkets.com adEgemonye 50 reinitiated coverage 50 Piper Jaffray Maintains 50 Reik Read 50 IPXL 50 Piper Jaffray reiterate 50 Nasdaq QCOR 50 Ton Gietman 50 Kenneth Zaslow 50 analyst Dorothy Lakner 50 DPP4 inhibitor 50 Commonly prescribed 50 analyst Matthew Fassler 50 Maintains Buy Rating 50 AstraZeneca AZN.L 行情 50 SGXP 50 Folotyn 50 analyst Les Funtleyder 50 Valeant Pharma 50 John Heinbockel 50 Daniel Junius 50 Momenta Pharmaceuticals Inc 50 ENZN 50 Drbul 50 analyst Navid Malik 50 Gilead GILD 50 omalizumab Xolair 50 Momenta Pharma MNTA 50 Human Genome Sciences HGSI 50 LymphoStat B belimumab 50 Reiterates Buy rating 50 analyst Subash Chandra 50 economist Tushar Poddar 50 Panzem 50 Novartis AG NVS NOVN.VX 50 Rexahn Pharmaceuticals 50 analyst Sasa Zorovic 50 analyst Matthew Borsch 50 Synta Pharmaceuticals 50 CYBX 50 Isis Pharmaceuticals ISIS 50 Vitaxin 50 Amylin Alkermes 50 Mark G. Foletta 50 Laboratories Rahway NJ 50 Denhoy 50 BioCentury NewsMakers 50 Aberman 50 Jeff Fidacaro 50 analyst Jacques Rousseau 50 analyst Sterling Auty 50 NBIX 50 maintaining Strong Speculative 50 Somaxon Pharmaceuticals 50 analyst Moshe Katri 50 UCB Keppra 50 Campath alemtuzumab 50 humanised monoclonal antibody 50 Cannacord Genuity 50 Jason Napodano 50 Anadys Pharmaceuticals 50 Capstone Investments 50 Nasdaq NPSP 50 Muken 50 Zyprexa Cymbalta 50 Co MRK 50 Abbott ABT 50 investigational oral hepatitis C 50 Steven Burakoff 50 Provenge prostate cancer 50 Vanlev 50 spokeswoman Mariann Caprino 50 Suji De Silva 50 motesanib 50 analyst Katherine Styponias 50 Ana Gupte 50 RhuDex 50 analyst Ajay Jain 50 Competitive Benchmarking Product 50 spokesman Tony Plohoros 50 analyst Mark Edelstone 50 NASDAQ AKRX 50 Axcan Pharma 50 analyst Stacey Widlitz 50 Jeff Klinefelter 50 Mark Astrachan 50 analyst Albert Savastano 50 Douglas Harned 50 Novartis Galvus 50 JMP Securities downgraded 50 Nasdaq MEDI 50 Mahesh Sanganeria 50 Fibrillex 50 Reiterates Sell 50 Avastin Herceptin 50 Inc NGSX 50 Maintained Buy 50 analyst Peter Nesvold 50 Kynapid 50 Tellabs Presentation 50 analyst Hamed Khorsand 50 Biegelsen wrote 50 Taranabant 50 Tolamba 50 analyst Vivek Arya 50 Inc CEPH 50 alicaforsen 50 Genentech Raptiva 50 ADRX 50 OMRIX Biopharmaceuticals 50 fusion enhancers 50 analyst Nigel Dally 50 Lilly Amylin 50 Gilead Sciences NASDAQ GILD 50 addressing idiopathic pulmonary 50 Equalweight 50 analyst Vivek Juneja 50 Pacific Growth Equities 50 analyst Walter Piecyk 50 TolerRx 50 lumiliximab 50 analyst Chad Friess 50 Sherri Scribner 50 analyst Kirk Materne 50 Dr. McHutchison 50 NASDAQ ANDS 50 Friedman Billings reiterate 50 Bristol Myers NYSE BMY 50 Sepracor Nasdaq SEPR 50 NASDAQ ALTH 50 Zeneus Holdings 50 Maintains Neutral Rating 50 Velcade bortezomib 50 John F. Thero 50 Genelabs Technologies Inc. 50 Paul Mansky 50 Tore Svanberg 50 Endo Pharmaceuticals ENDP 50 Sector Outperform 50 Camilo Lyon 50 Nasdaq MOGN 50 analyst Adrianne Shapira 50 analyst Mark Wiltamuth 50 BRAF inhibitor 50 Zavesca 50 Selzentry maraviroc 50 Acorda Therapeutics NASDAQ ACOR 50 marketperformer 50 analyst Darin Arita 50 Mkt Perform 50 Ocrelizumab 50 Edwin Mok 50 Maher Yaghi 50 Eliseo Salinas 50 GALNS 50 Medicis NYSE MRX 49 acute mania 49 NASDAQ SOMX specialty 49 Raises PT 49 Vitrasert R 49 Merck MRK Pfizer PFE 49 Robyn Karnauskas 49 Lead Bookrunning Manager 49 analyst Kathryn Huberty 49 Matthew Kather 49 Biogen NASDAQ BIIB 49 Analysts Reiterate 49 Nasdaq ANDS announced 49 analyst Mark Swartzberg 49 Gilead Sciences GILD 49 RDEA 49 analyst Aldo Mazzaferro 49 Nasdaq OPTR 49 Biomarin Pharm 49 NASDAQ IMGN 49 Brean Murray reiterates 49 WR Hambrecht analyst 49 analyst Elizabeth Osur 49 Outperform rating 49 Gattex 49 Analyst Ben Reitzes 49 DRRX 49 Nasdaq REGN 49 Achillion Pharmaceuticals Inc 49 Joel Fishbein 49 Piper Jaffray downgraded 49 anticholesterol 49 Genelabs Technologies 49 Lucentis ranibizumab 49 LymphoStat B TM 49 Goozner 49 Prexige lumiracoxib 49 analyst Nicholas Heymann 49 MS NYSE MWJ 49 analyst Koya Tabata 49 Marc Cluzel 49 Inc. Nasdaq SGXP 49 Auxilium Pharmaceuticals 49 Maintains Hold Rating 49 Scot Ciccarelli 49 Pablo Zuanic 49 equalweight rating 49 Alnylam Pharma 49 Luke Folta 49 FBR Capital reiterates 49 Darren Lehrich 49 Krensavage 49 known sulfonamide allergy 49 Canaccord Genuity Reiterates Buy 49 Glen Yeung 49 Standpoint Research downgraded 49 Ardour Capital 49 #/#/#-Citigroup 49 Diep Tran MD 49 NASDAQ SNTA 49 analyst Andrew Goodsall 49 Bruce Harting 49 MYGN G 49 Cephalon CEPH 49 FBR Capital NASDAQ FBCM 49 Maintains Sell 49 Vicriviroc 49 Spiriva inhaler 49 TransVax 49 Richard Kugele 49 Asenapine 49 analyst Colin McGranahan 49 Mkt Outperform 49 Changyou.com Limited NASDAQ CYOU 49 Jefferies NYSE JEF 49 Analyst Gene Munster 49 Amevive 49 Enbrel arthritis 49 Sector Perform rating 49 Morgan Stanley NYSE BDJ 49 Certriad 49 analyst Edward Yruma 49 Valproic acid 49 analyst Yuji Fujimori 49 Alimera Sciences Inc 49 NASDAQ AFFY 49 Troy Lahr 49 Armando Anido 49 Januvia sitagliptin 49 Joshua Shanker 49 Makoto Yamashita strategist 49 UBS Maintains Neutral 49 BLP# 49 Alexion Pharmaceuticals Inc 49 inhibit KSP 49 ALTH 49 Aryx 49 marketweight 49 Genentech Biogen 49 Prestara 49 taranabant 49 small molecule tyrosine 49 Maintains Outperform Rating 49 Zybrestat 49 OvaRex 49 ThinkEquity Partners LLC 49 GSK.L Quote Profile Research 49 Piper Jaffray Downgrades 49 Sav Neophytou 49 Citi Downgrades 49 Mylan Nasdaq MYL 49 reinitiates coverage 49 analyst Douglas Mavrinac 49 analyst Tal Liani 49 TooNiceStocks 49 Todd Raker 49 analyst Kurt Hallead 49 analyst Allan Mishan 49 Merrill Lynch Tradebot 49 Rilutek 49 Joseph Amaturo 49 macitentan 49 Personalized Immunotherapy 49 Jefferies Quarterdeck division 49 Needham Biotechnology 49 HC Wainwright 49 UCB Cimzia 49 apricitabine ATC 49 Sector Outperformer 49 Stephen Volkmann 49 Thomas Weisel 49 acetonide FA 49 AVEO Pharmaceuticals 49 economist Ryo Hino 49 CapStone Investments 49 Tad Piper 49 Brean Murray upgrades 49 Idenix Pharma 49 analyst Betsy Graseck 49 analyst Frederick Searby 49 Mr. Bentsur 49 OTC Zegerid 49 NASDAQ IPXL today 49 Recothrom 49 Neely JN Tamminga 49 Toremifene 49 Bob Drbul 49 Y. Edwin Mok 49 Medicis Pharma 49 RBC Capital NYSE RY 49 ZURICH AFX Novartis AG 49 analyst Kota Yuzawa 49 Launches Generic Version 49 analyst Ann Duignan 49 Ross Muken 49 Srini Pajjuri 49 candidate arimoclomol 49 Stacy Rasgon 49 analyst Sanjay Vidyarthi 49 Questcor Pharmaceuticals Inc. 49 Apricus Biosciences 49 analyst Rob Rutschow 49 Rommel Dionisio 49 Vernakalant 49 Pfizer Exubera 49 Patrick Walravens 49 Enzon Pharmaceuticals ENZN 49 blood clot preventer 49 Ron Bentsur 49 analyst Constance Maneaty 49 Vioxx Successor 49 Joseph Foresi 49 Neil K. Warma 48 Barclays Reiterates 48 XNPT 48 Palatin Technologies 48 Neurosearch AS 48 Torisel temsirolimus 48 analyst Michael Rehaut 48 Market Perform rating 48 NASDAQ BPAX 48 analyst Erik Suppiger 48 Analyst Dick Bove 48 NEOP 48 analyst Tero Weckroth 48 GSK Avandia 48 JMP Securities reiterate 48 Ms. Lewent 48 ViroPharma Nasdaq VPHM 48 BioCentury Future Leaders 48 VRTX